£211.24m
No changevs Oct 2024Active08273797Private limited companyLondon
ND PHARMA & BIOTECH LTD
Significant control: Jose Manuel Lopez (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Nd Pharma & Biotech Ltd sell?
Registered activity: Manufacture of other chemical products n.e.c. (SIC 20590). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ND PHARMA & BIOTECH LTD is an active private limited company (company number 08273797) incorporated on 30 October 2012, registered in London. Its registered activity is manufacture of other chemical products n.e.c. (SIC 20590). Latest small accounts cover the period ending 31 October 2025, showing net assets of £211.24m, with 0 employees on average. Net assets were unchanged on the prior period. Across the last 3 periods on record the net-asset trend is flat.
Peer position · net assets
By net assets it sits in the top quarter of 64 comparable companies in London (median £550, upper quartile £103k).
02
Ownership and control
- Dr. Jose Manuel Lopez
- owns 50–75% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 30 October 201213 yrs ago
- Next accounts due
- 31 July 2027in 281 days
- Confirmation statement due
- 13 November 2026in 21 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 20590
- Manufacture of other chemical products n.e.c.
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
vs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £211.24m | — | £210.00m | — | — | — | 0 |
| 31 October 2024 | £211.24m | — | £210.00m | — | — | — | 0 |
| 31 October 2023 | £211.24m | — | £211.55m | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £211,239,728 at 31 October 2025
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 30 October 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 281 days
- Confirmation statement duein 21 days
- Accounts period endNet assets £211.24m · small accounts
- Accounts period endNet assets £211.24m · small accounts
- Accounts period endNet assets £211.24m · small accounts
- Incorporated
08
Similar companies in London
- SULNOX RESEARCH & DEVELOPMENT LTDLondon · inc. Dec 2012
- DIAMOND MIST LTDLondon · inc. Jan 2013
- SEPARATOR INNOVATION LIMITEDActon · inc. Jun 2012
- HYONIC LTDLondon · inc. Apr 2013
- ARCIS BIOTECHNOLOGY LIMITEDLondon · inc. Apr 2013
- HAHYDRA TECHNOLOGIES LTDLondon · inc. Apr 2013
All companies incorporated on 30 October 2012 · in Oct 2012.
09
Reminders for ND PHARMA & BIOTECH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.